Debt-to-equity in % of ATAI Life Sciences N.V. from Q1 2022 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
ATAI Life Sciences N.V. quarterly Debt-to-equity history and growth rate from Q1 2022 to Q3 2025.
  • ATAI Life Sciences N.V. Debt-to-equity for the quarter ending September 30, 2025 was 37 %, a 49% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)

ATAI Life Sciences N.V. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 37 +12.2 +49% Sep 30, 2025
Q2 2025 32.8 +12.6 +62% Jun 30, 2025
Q1 2025 31.8 +13.5 +73.7% Mar 31, 2025
Q4 2024 28.7 +11.3 +64.7% Dec 31, 2024
Q3 2024 24.8 +8.71 +54% Sep 30, 2024
Q2 2024 20.2 +3.8 +23.1% Jun 30, 2024
Q1 2024 18.3 +4.17 +29.5% Mar 31, 2024
Q4 2023 17.4 +5.46 +45.7% Dec 31, 2023
Q3 2023 16.1 +6.08 +60.6% Sep 30, 2023
Q2 2023 16.4 +9.19 +127% Jun 30, 2023
Q1 2023 14.1 +8.06 +133% Mar 31, 2023
Q4 2022 12 Dec 31, 2022
Q3 2022 10 Sep 30, 2022
Q2 2022 7.24 Jun 30, 2022
Q1 2022 6.06 Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.